Narendra N Joshi,
Scientific Officer F
Advanced Centre for Treatment Research and Education in Cancer
Tata Memorial Centre, Kharghar
Navi Mumbai - 410 210
Maharashtra
E-mail: njoshi@actrec.gov.in
Publications:
1.
Joshi, N. N. , Kale, M. D., Hake, S. S. and Kannan, S. Transforming growth factor beta signaling pathway associated gene polymorphisms may explain lower breast cancer risk in western Indian women. PloS One. 2011. 6, e21866. [PubMed]
2.
Thorat, M. A., Datar, R. H. and Joshi, N. N. Cancer immunotherapeutics: raising the ante. The National Medical Journal of India. 2006. 19, 140-150. [PubMed]
3.
Shevde, L. A., Joshi, N. N. , Dudhat, S. B., Hawaldar, R. W. and Nadkarni, J. J. Immune functions, clinical parameters and hormone receptor status in breast cancer patients. Journal of Cancer Research and Clinical Oncology. 1999. 125, 313-320. [PubMed]
4.
Shevde, L. A., Rao, N. M., Joshi, N. N. , Shinde, S. R., Ghosh, S. N. and Nadkarni, J. J. Natural killer cell function and genetic instability in unaffected individuals from breast cancer families. European Journal of Cancer Prevention. 1998. 7, 141-148. [PubMed]
5.
Shevde, L. A., Joshi, N. N. , Shinde, S. R. and Nadkarni, J. J. Studies on functional status of circulating lymphocytes in unaffected members from cancer families. Human Immunology. 1998. 59, 373-381. [PubMed]
6.
Rao, N. M., Joshi, N. N. , Shinde, S. R., Advani, S. H. and Ghosh, S. N. Premature separation of centromere and aneuploidy: an indicator of high risk in unaffected individuals from familial breast cancer families? European Journal of Cancer Prevention. 1996. 5, 343-350. [PubMed]
7.
Joshi, N. N. , Mukhopadhyay, R., Advani, S. H. and Gangal, S. G. Production of interleukin-2 and expression of tac antigen in Hodgkin disease. Cancer Detection and Prevention. 1987. 1, 137-143. [PubMed]
Last modified on : Dec 9, 2015